Release
📈 Stocks
Pelthos Therapeutics Merges With Castle Creek to Advance Rare Disease Pipeline
(just now)
Pelthos Therapeutics and Castle Creek Biosciences combine forces to accelerate the development of a late-stage D-Fi franchise, aiming to address critical unmet…